From: Adaptive designs in clinical trials: from scientific advice to marketing authorisation to the European Medicine Agency
Completion year (N = 19)
Number n (%)
2008
1 (5%)
2011
4 (21%)
2012
3 (16%)
2013
6 (32%)
2014
2015
2 (11%)